Evaluation of the effect of oxytocin on structural and functional changes of the myocardium in experimental heart failure

The aim of the study was to evaluate the effect of oxytocin on the structural and functional reorganization of the myocardium in experimental heart failure (EHF) Material and methods. Heart failure was modeled on mature rats of both sexes of the Wistar line (n=36). From the 7th day of the experiment, oxytocin was administered to animals with EHF at a dose of 0.5 U / kg of body weight daily intramuscularly for a week. The obtained material (heart, left ventricular (LV) myocardium) was studied by light microscopy, morphometry, and immunohistochemistry (expression of caspase-3, bcl-2, ki-67 proteins). Results. A comprehensive analysis of histological preparations showed that in heart failure, pathological changes occur in all structures of the LV myocardium (in cardiomyocytes (CMC), vessels of the microvasculature, connective tissue stroma). Against the background of the introduction of oxytocin, there is an increase in the volume density (VD) of cardiac myocytes, capillaries and a decrease in the VD of stromal components. Oxytocin inhibition of the proapoptotic dominant and activation of reparative processes in the myocardium were established: there was a decrease in the number of caspase-3-positive cardiac myocytes and an increase in CMC expressing bcl-2 and ki-67 in animals of both sexes with EHF. Under the influence of oxytocin, a more significant activation of regenerative and antiapoptotic potential was revealed in the group of females with EHF. Conclusion. The totality of the data obtained as a result of the study indicates the cardioprotective effect of oxytocin on myocardial structures in heart failure, characterized by stimulation of vasculogenesis, inhibition of fibrosis and apoptosis, and activation of cellular adaptive myocardial remodeling pathways. The biological effect of oxytocin on the myocardium is characterized by gender-specific features of the realization of its effects, which gives a new understanding of the role of the oxytocinergic system in the heart.

1. Immunogistokhimicheskie metody: Rukovodstvo. Per. s angl. pod red. GA Franka i PG Mal'kova. Moscow, 2011 (in Russ.).

2. Liskova YuV, Salikova SP, Stadnikov AA. Structural Reorganization of the Myocardium in Ovariectomized Rats with Experimental Heart Failure after Melatonin Administration. Morphology. 2013;5(144):25–9 (in Russ.).

3. Liskova YuV, Salikova SP, Stadnikov AA. Experimental Models a Heart Failure: Condition of a Question and Results Own Research. Morphological Newsletter. 2014;1(22):46–53 (in Russ.).

4. Nozdrin VI, Barashkova SA, Semechko VV, Artemyev VN. Histologicheskaya technika: uchebnoe posobie. 3rd ed., supplement and revision. Omsk – Orel: Omsk Regional Printing House. 2006 (in Russ.).

5. Obrezan AG, Kulikov NV. Neuro-humoral Disbalance in Chronic Heart Failure: Classic and Modern Perspectives. Russian journal of cardiology. 2017;9(149):83–92 (in Russ.). dоi: 10.15829/1560-4071-2017-9-83-92

6. Bacova BS, Andelova K, Sykora M, Egan Benova T, Barancik M, Kurahara LH, et al. Does Myocardial Atrophy Represent Anti-Arrhythmic Phenotype? Biomedicines. 2022 Nov 4;10(11):2819–9. doi: 10.3390/biomedicines10112819

7. Buemann B, Uvnäs-Moberg K. Oxytocin may have a therapeutical potential against cardiovascular disease. Possible pharmaceutical and behavioral approaches. Medical Hypotheses. 2020 May;138:1095–7. doi: 10.1016/j.mehy.2020.109597

8. Carter HE, Schofield D, Shrestha R. Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups. Open Heart. 2019 Feb;6(1):e000939. doi: 10.1136/openhrt-2018-000939

9. Chatterjee NA, Singh JP. Autonomic modulation and cardiac arrhythmias: old insights and novel strategies. EP Europace. 2021 May 29;23(11):1708–21. doi: 10.1093/europace/euab118

10. Corsetti G, Chen-Scarabelli C, Romano C, Pasini E, Dioguardi FS, Onorati F, et al. Autophagy and Oncosis/Necroptosis Are Enhanced in Cardiomyocytes from Heart Failure Patients. Medical Science Monitor Basic Research. 2019 Feb 4;25:33–44. doi: 10.12659/MSMBR.913436

11. Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. Physiological Reviews. 2019 Oct 1;99(4):1765–817. doi: 10.1152/physrev.00022.2018

12. Dyavanapalli J, Rodriguez J, Rocha dos Santos C, Escobar JB, Dwyer MK, Schloen J, et al. Activation of Oxytocin Neurons Improves Cardiac Function in a Pressure-Overload Model of Heart Failure. JACC: Basic to Translational Science. 2020 May;5(5):484–97. doi: 10.1016/j.jacbts.2020.03.007

13. Ferrario CM. Cardiac remodelling and RAS inhibition. Therapeutic Advances in Cardiovascular Disease. 2016 Apr 21;10(3):162–71. doi: 10.1177/1753944716642677

14. Garrott K, Dyavanapalli J, Cauley E, Dwyer MK, Kuzmiak-Glancy S, Wang X, et al. Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure. Cardiovascular research. 2017 May 2;113(11):1318–28. doi: 10.1093/cvr/cvx084

15. Gong R, Jiang Z, Zagidullin N, Liu T, Cai B. Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration. Signal Transduction and Targeted Therapy. 2021 Jan 27;6(1):31. doi: 10.1038/s41392-020-00413-2

16. Gruber C, Nink N, Nikam S, Magdowski G, Kripp G, Voswinckel R, et al. Myocardial remodelling in left ventricular atrophy induced by caloric restriction. Journal of Anatomy. 2011 Nov 13;220(2):179–85. doi: 10.1111/j.1469-7580.2011.01453.x

17. Heckle MR, Flatt DM, Sun Y, Mancarella S, Marion TN, Gerling IC, et al. Atrophied cardiomyocytes and their potential for rescue and recovery of ventricular function. Heart failure reviews. 2016 Feb 12;21(2):191–8. doi: 10.1007/s10741-016-9535-x

18. Jankowski M, Wang D, Danalache B, Gangal M, Gutkowska J. Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 2010 Aug;299(2):H265–74. doi: 10.1152/ajpheart.00487.2009

19. Liu H, Xie Q, Xin BM, Liu JL, Liu Y, Li YZ, et al. Inhibition of autophagy recovers cardiac dysfunction and atrophy in response to tail-suspension. Life Sciences. 2015 Jan 15;121:1–9. doi: 10.1016/j.lfs.2014.10.023

20. Meng F, Xie B, Martin JF. Targeting the Hippo pathway in heart repair. Cardiovascular Research. 2021 Sep 16;118(11):2402–14. doi: 10.1093/cvr/cvab291

21. Penna C, Granata R, Tocchetti C, Gallo M, Alloatti G, Pagliaro P. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning. Current drug targets. 2015 Aug 12;16(8):843–67. doi: 10.2174/1389450116666150309115536

22. Pyner S. The heart is lost without the hypothalamus. Handbook of clinical neurology. 2021 Jan 1;(182):355–67. doi: 10.1016/B978-0-12-819973-2.00024-1

23. Ross JA, Stroud MJ. The Nucleus: Mechanosensing in cardiac disease. The International Journal of Biochemistry & Cell Biology. 2021 Aug;137:106035. doi: 10.1016/j.biocel.2021.106035

24. Schirone L, Forte M, Palmerio S, Yee D, Nocella C, Angelini F, et al. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling. Oxidative Medicine and Cellular Longevity. 2017;2017:1–16. doi: 10.1155/2017/3920195

25. Sudi S, Tanaka T, Oda S, Nishiyama K, Nishimura A, Sunggip C, et al. TRPC3-Nox2 axis mediates nutritional deficiency-induced cardiomyocyte atrophy. Scientific Reports. 2019 Jul 5;9(1):9785–5. doi: 10.1038/s41598-019-46252-2

26. Yap J, Chia SY, Lim FY, Allen JC, Teo L, Sim D, et al. The Singapore Heart Failure Risk Score: Prediction of Survival in Southeast Asian Patients. Annals, Academy of Medicine, Singapore/Annals of the Academy of Medicine, Singapore. 2019 Mar 15;48(3):86–94. doi: 10.47102/annals-acadmedsg.v48n3p86

27. Ytrehus K, Hulot JS, Perrino C, Schiattarella GG, Madonna R. Perivascular fibrosis and the microvasculature of the heart. Still hidden secrets of pathophysiology? Vascular Pharmacology. 2018 Aug;107:78–83. doi: 10.1016/j.vph.2018.04.007

28. Wasserman AH, Huang AR, Lewis-Israeli YR, Dooley MD, Mitchell AL, Venkatesan M, et al. Oxytocin promotes epicardial cell activation and heart regeneration after cardiac injury. Frontiers in Cell and Developmental Biology. 2022 Sep 30;10:985298. doi: 10.3389/fcell.2022.985298

29. Wsol A, Kasarello K, Kuch M, Gala K, Cudnoch-Jedrzejewska A. Increased Activity of the Intracardiac Oxytocinergic System in the Development of Postinfarction Heart Failure. BioMed research international. 2016 Jan 1;2016:1–7. doi: 10.1155/2016/3652068